Purchase Order 75N91025P00039
Award Date
12/5/24
Potential Completion Date
12/4/25
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $145,853.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Illumina, Inc. The contract is for a maintenance agreement for scientific equipment, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems and related reagents and consumables. Illumina is a for-profit manufacturer that has provided a range of genomic sequencing and analysis products and services...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $6,418.66 contract is for the provision of various Illumina sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems, along with related consumables, sample preparation kits, and support services. Illumina has previously served as a subcontractor on federal contracts supporting genomic...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a service agreement to support the Illumina MiSeq sequencer. The award has a ceiling value of $20,009.24 and a completion date of December 7, 2024. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously received prime federal contracts and subcontracts to support...
This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc. to maintain and provide preventive maintenance for an Illumina NextSeq 2000 sequencing system. The contract has a ceiling value of $48,209.00 and a performance period ending on March 19, 2026. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has a history of providing such products and...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $13,438.88 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support services, and bioinformatics products to support genomic research and diagnostics projects at the...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and analytical products. The $24,728.01 contract is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and...
This is a $15,388.08 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for a service agreement for a MiSeq M05802 sequencing system, with a completion date of December 7, 2025. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the NIH, CDC, USDA, and VA, to provide sequencing...
This is a $28,749.60 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Through this award, Illumina will provide the NCI with a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits,...
This is a firm fixed-price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics products. The contract has a ceiling...